Trademark: 98077157
Word
HYKU BIO
Status
Pending
Status Code
688
Status Date
Tuesday, July 2, 2024
Serial Number
98077157
Mark Type
4
Filing Date
Monday, July 10, 2023
Published for Opposition
Tuesday, May 7, 2024

Trademark Owner History
Umbra Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for targeting nucleophilic amino acid residues in proteins involved in human diseases, namely, cancer and for the treatment of human diseases, namely, cancer
42 Research and development in the field of covalent inhibitors targeting nucleophilic amino acid residues in proteins involved in human diseases, namely, cancer
"BIO"

Trademark Events
Jul 13, 2023
New Application Entered
Mar 19, 2024
Assigned To Examiner
Apr 1, 2024
Examiner's Amendment Entered
Aug 8, 2023
New Application Office Supplied Data Entered
Apr 1, 2024
Examiners Amendment -Written
Apr 1, 2024
Examiners Amendment E-Mailed
Apr 1, 2024
Notification Of Examiners Amendment E-Mailed
Apr 17, 2024
Notification Of Notice Of Publication E-Mailed
Apr 1, 2024
Approved For Pub - Principal Register
May 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 2, 2024
Noa E-Mailed - Sou Required From Applicant
May 7, 2024
Published For Opposition

Trademark Alertz updated from USPTO on 2030-01-24